mRNA is an endogenous ligand for Toll-like receptor 3.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2021 – May 2024Where it's discussed
-
X / Twitter27 posts
-
News8 articles
-
Blogs3 articles
-
YouTube2 videos
-
Facebook2 posts
AI synopsis
What people are saying
Discussions reflect skepticism about the relevance of mRNA's role as an endogenous ligand, emphasizing concerns over vaccine efficiency, side effects like thrombosis, and non-specific immune activation, with phrases like 'very inefficient' and 'poor side effects' indicating critical tones that influence the overall assessment.
Most posts express skepticism or highlight limitations of the findings, pointing to inefficiency and non-specific immune responses.
Posts show moderate curiosity, mainly questioning vaccine efficacy and mechanisms rather than deeply exploring the scientific details.
Several posts reference the technology and potential side effects, indicating some degree of engagement, though not highly detailed.
The discussions suggest that while the topic raises important concerns, the overall perceived impact on public health policies remains uncertain.
Abstract in brief
- The study shows that mRNA and other RNA sources released from or associated with damaged or necrotic cells can activate Toll-like receptor 3 (TLR3), a key receptor in the innate immune system that responds to viral double-stranded RNA.
- Laboratory experiments using human cell lines demonstrated that both synthetic and natural RNA can trigger TLR3, leading to immune responses such as cytokine production and cell activation, which involve signaling pathways like NF-kappaB and tyrosine phosphorylation.
- The findings suggest that endogenous RNA from damaged tissues may serve as a natural ligand for TLR3, playing a significant role in initiating or modulating immune responses during tissue injury or infection.]
Top posts
Most liked on X and BlueskyTLR-3は自然免疫のスイッチのひとつであるが、ウイルス由来のdsRNAだけでなく、内因性mRNAでもTLR-3の活性化因子として作用することがある。 https://t.co/2wATWWEJSu
The @jbiolchem paper "mRNA Is an Endogenous Ligand for Toll-like Receptor 3*" by Kariko et al. was referenced in today's announcement of the 2023 @NobelPrize in Physiology or Medicine! ➡️Read the paper here: https://t.co/FKGkAHRoUm. ➡️Announcement: https://t.co/6MtbtbvQnW. https://t.co/DnsKtn0TbM
@sankha_shubhra This paper was published almost 2 decades before covid, opening up a while new technology. Most people would call it ‘groundbreaking’. Anyway, you can blame alexander fleming for antibiotic resistance, surely! https://t.co/VpTr1by72V
@okBilmi10311253 @armanac05 @DrSarperSaglam 2004 yılında Karikó ve Weissman çok önemli bir buluş yaptılar: mRNA’ya karşı hücre içi TLR3 direncini keşfettiler. Bu direncin önüne geçebilmek mRNA aşılarının başarısı için şarttı. https://t.co/klPAzbFCNA
@zerohedge It only approved that the mRNA vaccine is very inefficient. Its anti-viral effects maybe not specific. Long chain of mRNA can trigger Toll-like receptor mediated nonspecific immune response and poor side effects such as thrombosis and cardiac infection https://t.co/Kx6CRBMcJB
All mentions
Pseudouridine: Insights into RNA Modifications and Their Impact
The realization that RNA can undergo posttranscriptional modifications marks a crucial milestone in genetics. This video explores pseudouridine, the most prevalent nucleoside modification in RNA, and its influence on…
RNA Modifications Suppress Immune Activation in Human Cells
This study examines how RNA activates toll-like receptors in the human immune system and shows that nucleoside modifications like methylation can suppress this activation, reducing immune responses and cytokine…
@Ihamessou1 @PBertaGard @OPECST_ 2/vous vouliez des élément de preuve qui confirme que la pseudoU permet une bonne traduction alors voici quelques exemples d'etudes: https://t.co/y9GzdLO19r https://t.co/NYpfPP9cyF https://t.co/UeI36f5hDR
mRNA Is an Endogenous Ligand for Toll-like Receptor 3* - Journal of Biological Chemistry https://t.co/kmZfEpxnAn
RT @ASBMB: The @jbiolchem paper "mRNA Is an Endogenous Ligand for Toll-like Receptor 3*" by Kariko et al. was referenced in today's announc…
RT @ASBMB: The @jbiolchem paper "mRNA Is an Endogenous Ligand for Toll-like Receptor 3*" by Kariko et al. was referenced in today's announc…
RT @virusfantom:
RT @virusfantom:
RT @virusfantom:
RT @ChestradRoy: @sankha_shubhra This paper was published almost 2 decades before covid, opening up a while new technology. Most people wou…
The @jbiolchem paper "mRNA Is an Endogenous Ligand for Toll-like Receptor 3*" by Kariko et al. was referenced in today's announcement of the 2023 @NobelPrize in Physiology or Medicine! ➡️Read the paper here: https://t.co/FKGkAHRoUm. ➡️Announcement: https://t.co/6MtbtbvQnW. https://t.co/DnsKtn0TbM
@sankha_shubhra This paper was published almost 2 decades before covid, opening up a while new technology. Most people would call it ‘groundbreaking’. Anyway, you can blame alexander fleming for antibiotic resistance, surely! https://t.co/VpTr1by72V
RT @wb29304326: TLR-3は自然免疫のスイッチのひとつであるが、ウイルス由来のdsRNAだけでなく、内因性mRNAでもTLR-3の活性化因子として作用することがある。 https://t.co/2wATWWEJSu
RT @wb29304326: TLR-3は自然免疫のスイッチのひとつであるが、ウイルス由来のdsRNAだけでなく、内因性mRNAでもTLR-3の活性化因子として作用することがある。 https://t.co/2wATWWEJSu
RT @wb29304326: TLR-3は自然免疫のスイッチのひとつであるが、ウイルス由来のdsRNAだけでなく、内因性mRNAでもTLR-3の活性化因子として作用することがある。 https://t.co/2wATWWEJSu
TLR-3は自然免疫のスイッチのひとつであるが、ウイルス由来のdsRNAだけでなく、内因性mRNAでもTLR-3の活性化因子として作用することがある。 https://t.co/2wATWWEJSu
@YlmazKu19119629 2004 yılında Karikó ve Weissman çok önemli bir buluş yaptılar: mRNA’ya karşı hücre içi TLR3 direncini keşfettiler. Bu direncin önüne geçebilmek mRNA aşılarının başarısı için şarttı. https://t.co/0y68R7013G https://t.co/qu0ULMwUhd
@okBilmi10311253 @armanac05 @DrSarperSaglam 2004 yılında Karikó ve Weissman çok önemli bir buluş yaptılar: mRNA’ya karşı hücre içi TLR3 direncini keşfettiler. Bu direncin önüne geçebilmek mRNA aşılarının başarısı için şarttı. https://t.co/klPAzbFCNA
RT @virusfantom:
@business @BW In human vaccine history, is any vaccine have to give 3 shots in 1 year? Any long chain of mRNA nucleic acid such as poly I:C can trigger nonspecific immune response. It also can trigger thrombosis and myocarditis via TLR receptor as mRNA vaccine did. https://t.co/Kx6CRBMcJB
@WSJ In vaccine history, Is any vaccine need 3 shots in 1 year? It only confirmed that mRNA vaccine is not efficient and target specific. Might be transiently active non-specific immune response by long mRNA chain no matter what it is. Need more research on it https://t.co/Kx6CRBMcJB
@zerohedge What's the real target of mRNA vaccine? Any mRNA can trigger nonspecific immune response in a short period via Toll-like receptor. That's why Moderna want to give 3rd shot? Long chain of mRNA also can trigger thrombosis and myocarditis via TLR receptor. https://t.co/Kx6CRBMcJB
@asymmetricalpha What's the real effect of mRNA vaccine? Any mRNA can trigger nonspecific immune response in a short period via Toll-like receptor. That's why Moderna want to give 3rd shot? Long chain of mRNA also can trigger thrombosis and myocarditis via TLR receptor. https://t.co/Kx6CRBMcJB
@zerohedge All mRNA vaccine may not generate COVID specific antibody as its COVID S-protein mRNA has to go into human cells first, using human cell machinery to produce spike protein, and secreted out to be recognized by APC cells to active immune response. However,https://t.co/Kx6CRBMcJB
@SwingTrader1114 @zerohedge Think about it, Which vaccine do we need to inject 3 times in one year? mRNA is long chain of nucleic acid, can trigger Toll-like receptor mediated nonspecific immune response and poor side effects such as thrombosis and cardiac infection https://t.co/Kx6CRBMcJB
RT @InoueKuniko: @zerohedge It only approved that the mRNA vaccine is very inefficient. Its anti-viral effects maybe not specific. Long cha…
@zerohedge It only approved that the mRNA vaccine is very inefficient. Its anti-viral effects maybe not specific. Long chain of mRNA can trigger Toll-like receptor mediated nonspecific immune response and poor side effects such as thrombosis and cardiac infection https://t.co/Kx6CRBMcJB
@zerohedge It only approved that the mRNA vaccine is very inefficient. Its anti-viral effects maybe not specific. Long chain of mRNA can trigger Toll-like receptor mediated nonspecific immune response and potential thrombosis and myocarditis https://t.co/Kx6CRBMcJB https://t.co/jBAYpXyTHS
ST
W
A
SR
D
KI
P
NN
MR
JC
Q
ZK
NS
ND
MS
L
C
D
ST
AK